C A Rothermundt, A Omlin, S Gillessen. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antineoplastic Agents/therapeutic useCarcinoma, Renal Cell/drug therapyCarcinoma, Renal Cell/secondaryDisease ProgressionFemaleHumansIndoles/therapeutic useKidney Neoplasms/drug therapyKidney Neoplasms/secondaryMiddle AgedPyrroles/therapeutic useRemission InductionRemission, SpontaneousSunitinib
Substances： See more » Antineoplastic AgentsIndolesPyrrolesSunitinib
Year: 2009 PMID： 19465428 DOI： 10.1093/annonc/mdp239
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976